Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine receptor modelling. A1/A2a selectivity.

Tiziano Tuccinardi1, Gabriella Ortore, Clementina Manera

  • 1Dipartimento di Scienze Farmaceutiche, Università di Pisa, Italy.

European Journal of Medicinal Chemistry
|January 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Discovery, Mechanism, and Application: An Integrated Strategy for Bioactive Natural Products.

Molecules (Basel, Switzerland)·2026
Same author

In Vitro Evaluation of Virucidal Effect of Polysaccharides Extracted and Purified from <i>Arthrospira platensis</i> and <i>Dunaliella salina</i> on Human Adenovirus Type 5 in A549 Cells.

Molecules (Basel, Switzerland)·2026
Same author

Protective Effects on Keratinocytes by Extracts Enriched in Polysaccharides from <i>Limnospira platensis</i> Grown Under Autotrophic and Mixotrophic Conditions.

Nutrients·2026
Same author

Sulfated Polysaccharide-Rich Fractions from Spirulina Platensis (SPPs) Exert Multi-Target Anticancer Activity in Non-Small Cell Lung Cancer (NSCLC) Cells.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Synthesis and biological evaluation of N-O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection.

European journal of medicinal chemistry·2025
Same author

Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration.

International journal of molecular sciences·2025
Same journal

Antiviral drug discovery for enterovirus 71: structure-based optimization of direct and host-targeted strategies.

European journal of medicinal chemistry·2026
Same journal

Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma.

European journal of medicinal chemistry·2026
Same journal

Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549/Taxol cells.

European journal of medicinal chemistry·2026
Same journal

Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y<sub>14</sub>R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].

European journal of medicinal chemistry·2026
Same journal

Identification of 3-arylquinoxalin-2(1H)-one derivatives targeting BRD4 BD1 as efficient anticancer agents.

European journal of medicinal chemistry·2026
Same journal

Discovery of novel ROCK inhibitors RX-021 and RX-044 with intraocular pressure-lowering effect for glaucoma treatment.

European journal of medicinal chemistry·2026
See all related articles

Structural differences in adenosine receptors (AR) influence drug selectivity. A(1)AR and A(2a)AR models reveal distinct binding pockets, primarily affecting lipophilic interactions for ligand binding and selectivity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Adenosine receptors (AR) are crucial G protein-coupled receptors involved in various physiological processes.
  • Understanding the structural basis of AR subtype selectivity is vital for developing targeted therapeutics.

Purpose of the Study:

  • To construct and validate three-dimensional models of the A(1) and A(2a) adenosine receptors.
  • To investigate the structural determinants of ligand selectivity between A(1)AR and A(2a)AR.

Main Methods:

  • Homology modeling using bovine rhodopsin as a template to build A(1)AR and A(2a)AR structures.
  • Docking analysis of selective agonists to validate the constructed receptor models.

Main Results:

Related Experiment Videos

  • The A(1)AR binding site cavity is smaller than that of the A(2a)AR.
  • Ligand selectivity is primarily driven by differences in lipophilic interactions, not hydrogen bonds, between the receptors.
  • Receptor structure differences, potentially due to proline residues, influence TM rearrangement and side chain positioning.

    • Conclusions:

    • Distinct binding site dimensions and lipophilic interaction capabilities underlie A(1)AR and A(2a)AR selectivity.
    • The study provides a structural basis for understanding differential ligand binding and designing subtype-selective AR modulators.